T. Rowe Price Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,261,891
| Closed | -$57.9M | – | 2608 |
|
|
2018
Q3 | $57.9M | Buy |
3,261,891
+642,082
| +25% | +$11.4M | 0.01% | 859 |
|
|
2018
Q2 | $36.2M | Sell |
2,619,809
-489,991
| -16% | -$6.76M | 0.01% | 1007 |
|
|
2018
Q1 | $28.3M | Buy |
+3,109,800
| New | +$28.3M | ﹤0.01% | 1063 |
|
|
2014
Q1 | – | Sell |
-300,500
| Closed | -$3.21M | – | 2528 |
|
|
2013
Q4 | $3.21M | Sell |
300,500
-1,400
| -0.5% | -$15K | ﹤0.01% | 1477 |
|
|
2013
Q3 | $4.02M | Buy |
301,900
+1,100
| +0.4% | +$14.7K | ﹤0.01% | 1456 |
|
|
2013
Q2 | $3.95M | Buy |
+300,800
| New | +$3.95M | ﹤0.01% | 1443 |
|